Business Context and Reporting Period
This Form 8-K is filed by N2OFF, Inc. (trading symbol: NITO) on March 19, 2025. The registrant is incorporated in Nevada and operates as an emerging growth company. The filing reports a material amendment to a previously disclosed Securities Purchase Agreement.
Key Financial Metrics
The filing does not provide current revenue, profit, cash flow, margin, debt, or liquidity metrics. The only financial data referenced relates to a prior capital raise:
- Private Placement Proceeds: Approximately $1,500,000 (gross) raised on December 10, 2024.
- Units Issued: 6,250,000 units and pre-funded units.
- Purchase Price: $0.24 per unit (less $0.00001 per pre-funded unit).
Material Changes
The primary material change reported is an amendment to the Securities Purchase Agreement dated December 10, 2024:
- Beneficial Ownership Limitation: Increased from 4.99% to 9.99% of the Company's outstanding capital stock.
- Scope: The amendment applies to the Agreement and associated Warrants (Common Warrants and Pre-Funded Warrants).
- Other Terms: All other terms and conditions of the original Agreement remain in full force and effect.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. No specific risks or contingencies are detailed beyond the standard incorporation by reference of the Amendment text. The filing does not disclose any unusual items.
Investor Verification Checklist
- Verify the full text of the Amendment to the Securities Purchase Agreement (Exhibit 10.1) to confirm the exact legal language regarding the 9.99% ownership cap.
- Confirm the current number of outstanding shares to calculate the maximum number of shares an investor can acquire under the new 9.99% limitation.
- Review the original December 10, 2024, 8-K filing to understand the full context of the Private Placement and warrant terms.
- Check for any subsequent filings that may impact the Company's liquidity or capital structure following this amendment.